How Renal Denervation for the Treatment of Resistant Hypertension Should be Implemented in a Multidisciplinary Framework
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
How Renal Denervation for the Treatment of Resistant Hypertension Should be Implemented in a Multidisciplinary Framework
-
ナレーター：
-
著者：
Drs Marwah Abdalla, Herbert Aronow, and Syed Ahsan discuss resistant hypertension, candidacy for renal denervation, and what procedural safety and follow-up look like in real-world practice.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1003189. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Secondary Hypertension: Evaluation and Management https://pubmed.ncbi.nlm.nih.gov/37115960/
Renal Sympathetic Denervation for Hypertension: Outside-In and Inside-Out https://pubmed.ncbi.nlm.nih.gov/32563528/
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://pubmed.ncbi.nlm.nih.gov/40811516/
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations https://pubmed.ncbi.nlm.nih.gov/39129887/
Primary Aldosteronism https://emedicine.medscape.com/article/127080-overview
Long-Term Outcomes After Catheter-Based Renal Artery Denervation for Resistant Hypertension: Final Follow-Up of the Randomised SYMPLICITY HTN-3 Trial https://pubmed.ncbi.nlm.nih.gov/36130612/
Predicting Renal Denervation Response in Resistant High Blood Pressure by Arterial Stiffness Assessment: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/36013092/
Effects of Renal Denervation on Kidney Function and Long-Term Outcomes: 3-Year Follow-Up From the Global SYMPLICITY Registry https://pubmed.ncbi.nlm.nih.gov/30907413/
Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension https://pubmed.ncbi.nlm.nih.gov/33390042/
Renal Denervation After USA FDA Approval: An Update From an Interventional Cardiologist's Perspective https://pubmed.ncbi.nlm.nih.gov/40429549/
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension https://clinicaltrials.gov/study/NCT06526858
Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension https://pubmed.ncbi.nlm.nih.gov/37467498/